Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00568958 · ClinicalTrials.gov registry record · Phase 4
Naltrexone for Heavy Drinking in Young Adults
A Phase 4 study of Alcoholism and Alcohol Consumption, sponsored by Yale University.
- Completed
- Registry status
- Phase 4
- Development phase
- 140
- Enrollment target
- 1
- Study location
NCT00568958 is a Phase 4 study of Alcoholism and Alcohol Consumption that has completed, run by Yale University. The registered enrollment target is 140 participants, below the 373-participant average among 65 other Alcoholism trials with a reported enrollment target (62% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00568958, a Phase 4 study of Alcoholism and Alcohol Consumption, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 140 participants
- Enrollment target
- 1
- Study location
Study Summary
In this study, 140 heavy drinking young adults (aged 18-25) will be provided with brief counseling and either naltrexone, a medication that is FDA-approved for the treatment of alcohol dependence, or placebo over the course of 8 weeks. A novel strategy will be used for administering low-dose naltrexone, in which daily dosing will be combined with targeted dosing in anticipation of high-risk situations. The main hypotheses are that daily + targeted naltrexone will result in greater reductions in frequency of heavy and any drinking compared with daily + targeted placebo.
Conditions Studied
Interventions
- DRUG naltrexone
- BEHAVIORAL BASICS counseling
- DRUG placebo naltrexone
Study Locations (1)
Connecticut
- Connecticut Mental Health Center - Substance Abuse Treatment Unit - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2008-02 |
| Est. Completion | 2012-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00568958
The ClinicalTrials.gov registry entry for NCT00568958 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 373-participant average among 65 other Alcoholism trials with a reported enrollment target (62% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Alcoholism appearing as the primary indexed condition, and to 3 interventions - of which naltrexone is the first listed.
NCT00568958 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT00568958 about?
NCT00568958 is a clinical study titled "Naltrexone for Heavy Drinking in Young Adults". In this study, 140 heavy drinking young adults (aged 18-25) will be provided with brief counseling and either naltrexone, a medication that is FDA-approved for the treatment of alcohol dependence, or placebo over the course of 8 weeks. A novel strategy will be used for administering low-dose naltrex...
What is the current status of trial NCT00568958?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 140 participants. The study started on 2008-02. Estimated completion is 2012-12.
What conditions does trial NCT00568958 study?
This clinical trial studies the following conditions: Alcoholism, Alcohol Consumption, Alcoholic Intoxication, Alcohol-induced Disorders.
What interventions are being tested in trial NCT00568958?
The interventions under investigation include: naltrexone (DRUG), BASICS counseling (BEHAVIORAL), placebo naltrexone (DRUG).
Who is sponsoring clinical trial NCT00568958?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00568958 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcoholism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Naltrexone in AUD Reward Drinkers
RECRUITING · Phase 4
-
Naltrexone Treatment of Alcohol Abuse in Schizophrenia
COMPLETED · Phase 4
-
Naltrexone, Craving, and Drinking
COMPLETED · Phase 4
-
Sertraline Pharmacotherapy for Alcoholism Subtypes
COMPLETED · Phase 4
-
Managing Alcoholism in People Who Do Not Respond to Naltrexone
COMPLETED · Phase 4
-
Drug Treatment for Depressed Alcoholics (Naltrexone/Fluoxetine)
COMPLETED · Phase 4
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.